title: EURTAC first line therapy for non small cell lung carcinoma in epidermal growth factor receptor mutation positive patients: A choice between two TKIs.
authors: British Columbia CancerAgency Vancouver Center, University of British Columbia, Vancouver, BC, Canada.
authors: Barbara
authors: B
authors: Melosky